POMDOCTOR to Reverse ADS Split, Consolidating 18 ADSs into One on June 22
POM•POMDOCTOR will execute a one-for-eighteen reverse ADS split effective June 22, 2026, converting one ADS into three Class A ordinary shares. The change is expected to proportionally increase ADS trading price, with fractional entitlements aggregated and sold for cash.
1. ADS Ratio Change Proposal
POMDOCTOR plans to amend its ADS ratio from one ADS representing one-sixth of a Class A ordinary share to one ADS representing three Class A ordinary shares. This adjustment equates to a one-for-eighteen reverse ADS split and will not alter the total number of underlying Class A ordinary shares.
2. Exchange Mechanics and Timeline
A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed to reflect the new ratio, with the split anticipated to take effect on or about June 22, 2026. Holders in both the Direct Registration System and The Depository Trust Company will have existing ADSs automatically exchanged by Citibank, N.A., the depositary bank.
3. Trading Price Implications
The company expects the reverse ADS split to proportionally increase the trading price per ADS, though no guarantee exists that post-split prices will equal or exceed pre-split levels multiplied by eighteen. Fractional entitlements will be aggregated and sold, with net cash proceeds distributed to ADS holders.
